Global Epilepsy Drugs Market to grow at a CAGR of 4.45% during 2016-2020

MarketResearchReports.Biz has announced addition of new report “Global Epilepsy Drugs Market 2016-2020” to its database.

About the Epilepsy Drugs Market

Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors, birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases have an unknown etiology.


Etiology varies according to the age of a person. Some individuals genetically inherit the disease while the cause of the disease in others is unknown. Head injuries, tumors, autism spectrum disorder, or stroke can also cause the disorder.

Technavios analysts forecast the global epilepsy drugs market to grow at a CAGR of 4.45% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global epilepsy drugs market for 2016-2020. To calculate the market size, the report considers revenue generated from the sales of branded and generic drugs used to treat and prevent epilepsy and related seizures. The report also considers the revenues to be generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of marketed drugs during the forecast period.

The market is divided into the following segments based on geography:




Technavio’s report, Global Epilepsy Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Sample Copy of Report at


Key vendors






Other prominent vendors


Acorda Therapeutics

Alexza Pharmaceuticals

Aprecia Pharmaceuticals

Aurobindo Pharma

Biscayne Pharmaceuticals

CURx Pharmaceuticals

Dainippon Sumitomo Pharma


  1. Hoffmann-La Roche

Grupo Ferrer Internacional

GW Pharmaceuticals

Insero Health

INSYS Therapeutics

Janssen Pharmaceuticals

Ligand Pharmaceuticals

  1. Lundbeck

MarcoPolo Pharmaceuticals

Marinus Pharmaceuticals





Orphelia Pharma

SAGE Therapeutics


Sedor Pharmaceuticals


SK Biopharmaceuticals

Sun Pharmaceutical

Sunovion Pharmaceuticals (US)

Supernus Pharmaceuticals


Turing Pharmaceuticals


Valeant Pharmaceutical



Market driver

Tentative approval of late-stage pipeline molecules

For a full, detailed list, view our report


Market challenge

Social stigma associated with epilepsy

For a full, detailed list, view our report


Market trend

Reformulation of marketed drugs

For a full, detailed list, view our report


Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?


About Us is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Browse Latest Industry Press Release


Contact Us

State Tower

90 State Street, Suite 700

Albany, NY 12207

United States

Tel: +1-518-621-2074



Follow us on LinkedIn:

%d bloggers like this: